Transcode Therapeutics Inc (RNAZ)

Feb 06, 2025

Clinical Trials News Live Feed - StockTitan

Feb 06, 2025

Feb 06, 2025

Stock market today: Lipella Pharmaceuticals +99.22%, Digital Turbine +68.90% among top gainers in early trading - Business Upturn

Feb 06, 2025

Feb 06, 2025

Transcode Therapeutics completes Cohort 3 dosing in Phase 1 trial of TTX-MC138 - TipRanks

Feb 06, 2025

Feb 06, 2025

TransCode reports positive phase 1 trial progress for cancer therapy - Investing.com

Feb 06, 2025

Feb 06, 2025

TransCode reports positive phase 1 trial progress for cancer therapy By Investing.com - Investing.com UK

Feb 06, 2025

Feb 06, 2025

Clinical Trial Milestone: TransCode's Cancer Drug Shows Zero Toxicity While Doubling Dose - StockTitan

Feb 06, 2025

Feb 04, 2025

TransCode Therapeutics, Inc. Announces Adjournment of Special Meeting and Information for Adjourned Special Meeting - Longview News-Journal

Feb 04, 2025

Feb 04, 2025

Shareholder Participation Crisis: TransCode's Critical Warrant Vote Stalls at 30% - StockTitan

Feb 04, 2025

Jan 29, 2025

How Is The Market Feeling About TransCode Therapeutics? - Benzinga

Jan 29, 2025

Jan 29, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Jan 29, 2025

Jan 28, 2025

Stock market news: TransCode Therapeutics +133.97%, Diginex +27.49% among top gainers during mid day trading - Business Upturn

Jan 28, 2025

Jan 28, 2025

Are Investors Keen On Selling Holdings In GSK Plc ADR (NYSE: GSK)? - Stocks Register

Jan 28, 2025

Jan 28, 2025

Dow Inc (NYSE: DOW) Is A Buzzing Hot Stock - Stocks Register

Jan 28, 2025

Jan 28, 2025

Stock market today: Sentage Holdings +70.79%, Planet Image International +64.29% among top gainers in early trading - Business Upturn

Jan 28, 2025

Jan 24, 2025

TransCode Therapeutics Shares Are Surging Today: What's Going On? - Benzinga

Jan 24, 2025

Jan 24, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Jan 24, 2025

Jan 23, 2025

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.93% - Investing.com UK

Jan 23, 2025

Jan 14, 2025

Transcode Therapeutics doses first patient in third cohort of Phase 1trial - TipRanks

Jan 14, 2025

Jan 14, 2025

TransCode's TTX-MC138 Cancer Trial Advances: First Patient Dosed in Cohort 3 with Doubled Dose - StockTitan

Jan 14, 2025

Jan 13, 2025

Transcode Therapeutics stock hits 52-week low at $3.20 - Investing.com India

Jan 13, 2025

Jan 07, 2025

Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements - PR Newswire

Jan 07, 2025

Jan 07, 2025

TransCode Therapeutics Secures Nasdaq Listing Status After Meeting Critical Requirements - StockTitan

Jan 07, 2025

Jan 04, 2025

SABBY MANAGEMENT, LLC Acquires Shares in TransCode Therapeutics Inc - GuruFocus.com

Jan 04, 2025

Dec 29, 2024

TransCode Therapeutics, Inc. (NASDAQ:RNAZ) Short Interest Update - Defense World

Dec 29, 2024

Dec 28, 2024

Financial Analysis: TransCode Therapeutics (NASDAQ:RNAZ) & Eliem Therapeutics (NASDAQ:ELYM) - Defense World

Dec 28, 2024

Dec 23, 2024

HC Wainwright Has Optimistic Outlook of RNAZ FY2024 Earnings - Defense World

Dec 23, 2024

Dec 21, 2024

Analysts Issue Forecasts for RNAZ Q1 Earnings - Defense World

Dec 21, 2024

Dec 20, 2024

TransCode Therapeutics (NASDAQ:RNAZ) Stock Price Expected to Rise, HC Wainwright Analyst Says - Defense World

Dec 20, 2024

Dec 19, 2024

H.C. Wainwright raises TransCode Therapeutics target following SRC go-ahead for Cohort 3 - Investing.com

Dec 19, 2024

Dec 18, 2024

TransCode Therapeutics Announces Safety Review Committee Approval of Opening Third Cohort and Preliminary Results from First Cohort in Phase 1 TTX-MC138 Clinical Trial - StreetInsider.com

Dec 18, 2024

Dec 18, 2024

TransCode advances to third patient group in cancer trial - Investing.com India

Dec 18, 2024

Dec 18, 2024

Dow Surges 150 Points, US Current Account Deficit Widens In Q3 - Benzinga

Dec 18, 2024

Dec 18, 2024

Transcode announces SRC approved third cohort in TTX-MC138 clinical trial - TipRanks

Dec 18, 2024

Dec 18, 2024

RNAZTransCode Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Dec 18, 2024

Dec 13, 2024

Transcode Therapeutics stock hits 52-week low at $6.89 By Investing.com - Investing.com Canada

Dec 13, 2024

Dec 04, 2024

TransCode Therapeutics to execute 1-for-33 reverse stock split on Dec 4 - MSN

Dec 04, 2024

Dec 02, 2024

Janux, Vir stocks rally on positive data for Janux drug JANX007 - MSN

Dec 02, 2024

Dec 02, 2024

TransCode Therapeutics Raises $8M in Private Placement - TipRanks

Dec 02, 2024

Dec 02, 2024

Why TransCode Therapeutics (RNAZ) Stock Is Diving - Benzinga

Dec 02, 2024

Nov 30, 2024

TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split - The Manila Times

Nov 30, 2024

Nov 29, 2024

TransCode Therapeutics Announces Reverse Stock Split - TipRanks

Nov 29, 2024

Nov 29, 2024

TransCode Therapeutics Announces 1-for-33 Reverse Stock Split to Meet Nasdaq Requirements | RNAZ Stock News - StockTitan

Nov 29, 2024

Nov 28, 2024

TransCode Therapeutics announces $8M private offering - MSN

Nov 28, 2024

Nov 28, 2024

Transcode Therapeutics issues 21.2M shares at 37.7c in private placement - Yahoo Finance

Nov 28, 2024